annual CAPEX:
$1.05B+$344.00M(+48.66%)Summary
- As of today (May 21, 2025), MRNA annual capital expenditures is $1.05 billion, with the most recent change of +$344.00 million (+48.66%) on December 31, 2024.
- During the last 3 years, MRNA annual CAPEX has risen by +$767.00 million (+270.07%).
- MRNA annual CAPEX is now at all-time high.
Performance
MRNA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$127.00M-$395.00M(-75.67%)Summary
- As of today (May 21, 2025), MRNA quarterly capital expenditures is $127.00 million, with the most recent change of -$395.00 million (-75.67%) on March 31, 2025.
- Over the past year, MRNA quarterly CAPEX has dropped by -$69.00 million (-35.20%).
- MRNA quarterly CAPEX is now -75.67% below its all-time high of $522.00 million, reached on December 31, 2024.
Performance
MRNA quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$982.00M-$69.00M(-6.57%)Summary
- As of today (May 21, 2025), MRNA TTM capital expenditures is $982.00 million, with the most recent change of -$69.00 million (-6.57%) on March 31, 2025.
- Over the past year, MRNA TTM CAPEX has increased by +$192.00 million (+24.30%).
- MRNA TTM CAPEX is now -6.57% below its all-time high of $1.05 billion, reached on December 31, 2024.
Performance
MRNA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
MRNA CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.7% | -35.2% | +24.3% |
| 3 y3 years | +270.1% | -3.8% | +157.7% |
| 5 y5 years | +3184.4% | +2016.7% | +3129.7% |
MRNA CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +270.1% | -75.7% | +46.0% | -6.6% | +157.7% |
| 5 y | 5-year | at high | +3184.4% | -75.7% | +2016.7% | -6.6% | +3129.7% |
| alltime | all time | at high | >+9999.0% | -75.7% | >+9999.0% | -6.6% | >+9999.0% |
MRNA CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $127.00M(-75.7%) | $982.00M(-6.6%) |
| Dec 2024 | $1.05B(+48.7%) | $522.00M(+245.7%) | $1.05B(+40.3%) |
| Sep 2024 | - | $151.00M(-17.0%) | $749.00M(+1.5%) |
| Jun 2024 | - | $182.00M(-7.1%) | $738.00M(-6.6%) |
| Mar 2024 | - | $196.00M(-10.9%) | $790.00M(+11.7%) |
| Dec 2023 | $707.00M(+76.8%) | $220.00M(+57.1%) | $707.00M(+22.1%) |
| Sep 2023 | - | $140.00M(-40.2%) | $579.00M(+9.7%) |
| Jun 2023 | - | $234.00M(+107.1%) | $528.00M(+38.6%) |
| Mar 2023 | - | $113.00M(+22.8%) | $381.00M(-4.8%) |
| Dec 2022 | $400.00M(+40.8%) | $92.00M(+3.4%) | $400.00M(-6.5%) |
| Sep 2022 | - | $89.00M(+2.3%) | $428.00M(-2.3%) |
| Jun 2022 | - | $87.00M(-34.1%) | $438.00M(+15.0%) |
| Mar 2022 | - | $132.00M(+10.0%) | $381.00M(+34.2%) |
| Dec 2021 | $284.00M(+317.6%) | $120.00M(+21.2%) | $284.00M(+51.1%) |
| Sep 2021 | - | $99.00M(+230.0%) | $188.00M(+74.1%) |
| Jun 2021 | - | $30.00M(-14.3%) | $108.00M(+11.3%) |
| Mar 2021 | - | $35.00M(+45.8%) | $97.00M(+42.6%) |
| Dec 2020 | $68.00M(+112.5%) | $24.00M(+26.3%) | $68.00M(+33.1%) |
| Sep 2020 | - | $19.00M(0.0%) | $51.11M(+31.7%) |
| Jun 2020 | - | $19.00M(+216.7%) | $38.82M(+27.7%) |
| Mar 2020 | - | $6.00M(-15.6%) | $30.41M(-5.0%) |
| Dec 2019 | $32.00M(-69.7%) | $7.11M(+5.9%) | $32.00M(-16.9%) |
| Sep 2019 | - | $6.71M(-36.6%) | $38.53M(-33.5%) |
| Jun 2019 | - | $10.59M(+39.4%) | $57.96M(-28.8%) |
| Mar 2019 | - | $7.59M(-44.3%) | $81.45M(-23.0%) |
| Dec 2018 | $105.77M(+81.1%) | $13.64M(-47.8%) | $105.77M(+14.8%) |
| Sep 2018 | - | $26.14M(-23.3%) | $92.13M(+39.5%) |
| Jun 2018 | - | $34.08M(+6.8%) | $66.06M(+104.6%) |
| Mar 2018 | - | $31.91M(>+9900.0%) | $32.28M(+8509.1%) |
| Dec 2017 | $58.40M(+76.2%) | $0.00(-100.0%) | $375.00K(0.0%) |
| Sep 2017 | - | $75.00K(-75.0%) | $375.00K(+25.0%) |
| Jun 2017 | - | $300.00K(+1204.3%) | $300.00K(-25.7%) |
| Dec 2016 | $33.14M(>+9900.0%) | - | - |
| Dec 2015 | $45.00K(+1400.0%) | - | - |
| Dec 2011 | $3000.00(-99.3%) | - | - |
| Dec 2010 | $404.00K(+329.8%) | $23.00K(-89.7%) | $404.00K(+5.2%) |
| Sep 2010 | - | $223.00K(+596.9%) | $384.00K(+57.4%) |
| Jun 2010 | - | $32.00K(-74.6%) | $244.00K(+10.9%) |
| Mar 2010 | - | $126.00K(+4100.0%) | $220.00K(+134.0%) |
| Dec 2009 | $94.00K(-23.6%) | $3000.00(-96.4%) | $94.00K(-7.8%) |
| Sep 2009 | - | $83.00K(+937.5%) | $102.00K(+50.0%) |
| Jun 2009 | - | $8000.00(-27.3%) | $68.00K(-44.7%) |
| Dec 2008 | $123.00K(-96.9%) | $11.00K(-77.6%) | $123.00K(-79.4%) |
| Sep 2008 | - | $49.00K(+88.5%) | $596.00K(-54.2%) |
| Jun 2008 | - | $26.00K(-29.7%) | $1.30M(-44.1%) |
| Mar 2008 | - | $37.00K(-92.4%) | $2.33M(-41.8%) |
| Dec 2007 | $4.01M | $484.00K(-35.9%) | $4.01M(-27.3%) |
| Sep 2007 | - | $755.00K(-28.4%) | $5.51M(-30.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | $1.05M(-38.4%) | $7.96M(-24.6%) |
| Mar 2007 | - | $1.71M(-13.9%) | $10.55M(+3.5%) |
| Dec 2006 | $10.20M(+105.4%) | $1.99M(-37.8%) | $10.20M(+13.8%) |
| Sep 2006 | - | $3.20M(-12.4%) | $8.97M(+20.5%) |
| Jun 2006 | - | $3.65M(+168.5%) | $7.44M(+49.6%) |
| Mar 2006 | - | $1.36M(+79.7%) | $4.97M(+0.2%) |
| Dec 2005 | $4.97M(+129.5%) | $757.00K(-54.8%) | $4.97M(+4.0%) |
| Sep 2005 | - | $1.67M(+41.2%) | $4.78M(+27.4%) |
| Jun 2005 | - | $1.19M(-12.3%) | $3.75M(+28.8%) |
| Mar 2005 | - | $1.35M(+138.3%) | $2.91M(+34.6%) |
| Dec 2004 | $2.16M(-2.9%) | $567.00K(-12.4%) | $2.16M(-9.8%) |
| Sep 2004 | - | $647.00K(+86.5%) | $2.40M(+6.5%) |
| Jun 2004 | - | $347.00K(-42.5%) | $2.25M(+8.4%) |
| Mar 2004 | - | $603.00K(-24.7%) | $2.08M(-6.8%) |
| Dec 2003 | $2.23M(-5.7%) | $801.00K(+60.2%) | $2.23M(-3.4%) |
| Sep 2003 | - | $500.00K(+189.0%) | $2.31M(-3.2%) |
| Jun 2003 | - | $173.00K(-77.1%) | $2.38M(-19.8%) |
| Mar 2003 | - | $755.00K(-14.2%) | $2.97M(+25.8%) |
| Dec 2002 | $2.36M(+1552.4%) | $880.00K(+52.8%) | $2.36M(+56.9%) |
| Sep 2002 | - | $576.00K(-24.3%) | $1.51M(+52.9%) |
| Jun 2002 | - | $761.00K(+421.2%) | $985.00K(+313.9%) |
| Mar 2002 | - | $146.00K(+534.8%) | $238.00K(+66.4%) |
| Dec 2001 | $143.00K(-75.9%) | $23.00K(-58.2%) | $143.00K(-17.8%) |
| Sep 2001 | - | $55.00K(+292.9%) | $174.00K(-6.5%) |
| Jun 2001 | - | $14.00K(-72.5%) | $186.00K(-36.1%) |
| Mar 2001 | - | $51.00K(-5.6%) | $291.00K(-50.9%) |
| Dec 2000 | $593.00K(-80.2%) | $54.00K(-19.4%) | $593.00K(-65.9%) |
| Sep 2000 | - | $67.00K(-43.7%) | $1.74M(-37.3%) |
| Jun 2000 | - | $119.00K(-66.3%) | $2.77M(-9.2%) |
| Mar 2000 | - | $353.00K(-70.6%) | $3.05M(+1.8%) |
| Dec 1999 | $3.00M(+400.0%) | $1.20M(+9.1%) | $3.00M(+57.9%) |
| Sep 1999 | - | $1.10M(+175.0%) | $1.90M(+90.0%) |
| Jun 1999 | - | $400.00K(+33.3%) | $1.00M(+25.0%) |
| Mar 1999 | - | $300.00K(+200.0%) | $800.00K(+33.3%) |
| Dec 1998 | $600.00K(0.0%) | $100.00K(-50.0%) | $600.00K(0.0%) |
| Sep 1998 | - | $200.00K(0.0%) | $600.00K(+20.0%) |
| Jun 1998 | - | $200.00K(+100.0%) | $500.00K(+25.0%) |
| Mar 1998 | - | $100.00K(0.0%) | $400.00K(-33.3%) |
| Dec 1997 | $600.00K(+200.0%) | $100.00K(0.0%) | $600.00K(+20.0%) |
| Sep 1997 | - | $100.00K(0.0%) | $500.00K(0.0%) |
| Jun 1997 | - | $100.00K(-66.7%) | $500.00K(+25.0%) |
| Mar 1997 | - | $300.00K(+200.0%) | $400.00K(+300.0%) |
| Dec 1996 | $200.00K(+100.0%) | - | - |
| Sep 1996 | - | $100.00K(>+9900.0%) | $100.00K(0.0%) |
| Jun 1996 | $100.00K(0.0%) | $0.00(0.0%) | $100.00K(0.0%) |
| Mar 1996 | - | $0.00(0.0%) | $100.00K(0.0%) |
| Dec 1995 | - | $0.00(-100.0%) | $100.00K(0.0%) |
| Sep 1995 | - | $100.00K | $100.00K |
| Jun 1995 | $100.00K | - | - |
FAQ
- What is Moderna annual capital expenditures?
- What is the all time high annual CAPEX for Moderna?
- What is Moderna annual CAPEX year-on-year change?
- What is Moderna quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Moderna?
- What is Moderna quarterly CAPEX year-on-year change?
- What is Moderna TTM capital expenditures?
- What is the all time high TTM CAPEX for Moderna?
- What is Moderna TTM CAPEX year-on-year change?
What is Moderna annual capital expenditures?
The current annual CAPEX of MRNA is $1.05B
What is the all time high annual CAPEX for Moderna?
Moderna all-time high annual capital expenditures is $1.05B
What is Moderna annual CAPEX year-on-year change?
Over the past year, MRNA annual capital expenditures has changed by +$344.00M (+48.66%)
What is Moderna quarterly capital expenditures?
The current quarterly CAPEX of MRNA is $127.00M
What is the all time high quarterly CAPEX for Moderna?
Moderna all-time high quarterly capital expenditures is $522.00M
What is Moderna quarterly CAPEX year-on-year change?
Over the past year, MRNA quarterly capital expenditures has changed by -$69.00M (-35.20%)
What is Moderna TTM capital expenditures?
The current TTM CAPEX of MRNA is $982.00M
What is the all time high TTM CAPEX for Moderna?
Moderna all-time high TTM capital expenditures is $1.05B
What is Moderna TTM CAPEX year-on-year change?
Over the past year, MRNA TTM capital expenditures has changed by +$192.00M (+24.30%)